0001209191-21-005492.txt : 20210126 0001209191-21-005492.hdr.sgml : 20210126 20210126182019 ACCESSION NUMBER: 0001209191-21-005492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210125 FILED AS OF DATE: 20210126 DATE AS OF CHANGE: 20210126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dentzer James E CENTRAL INDEX KEY: 0001400977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30347 FILM NUMBER: 21555785 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURIS INC CENTRAL INDEX KEY: 0001108205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043505116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-503-6500 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-25 0 0001108205 CURIS INC CRIS 0001400977 Dentzer James E C/O CURIS, INC. 128 SPRING STREET BUILDING C SUITE 500 LEXINGTON MA 02421 1 1 0 0 President & CEO Common Stock 2021-01-25 4 S 0 2283 10.96 D 70362 D Common Stock 2021-01-26 4 S 0 3094 10.5876 D 67268 D Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018. This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations. William Steinkrauss, attorney-in-fact 2021-01-26